基本資料
種類: ETF
費用比率%: 0.44
資產淨值: 171.02
成立日期: 05/02/2001
 
分析
市值分佈:
87.19%
大市值
8.91%
中市值
3.58%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 251  
0%
 
100%
     10大 (49.74%)
代號 名稱 佔比% 持有日期
CTNMContineum Therapeutics0.0328/02/2026
AVXLAnavex Life Sciences Corp0.0328/02/2026
PRTAProthena Corp0.0328/02/2026
MRVIMaravai LifeSciences Holdings0.0328/02/2026
LENZLENZ Therapeutics0.0328/02/2026
ABSIAbsci Corp0.0328/02/2026
PEPGPepGen0.0328/02/2026
SLDBSolid Biosciences0.0328/02/2026
DSGNDesign Therapeutics0.0328/02/2026
IMMPImmutep Limited0.0328/02/2026
AUTLAutolus Therapeutics plc0.0328/02/2026
NGNENeurogene0.0328/02/2026
FLGTFulgent Genetics0.0328/02/2026
AVIRAtea Pharmaceuticals0.0228/02/2026
KYTXKyverna Therapeutics0.0228/02/2026
DNAGinkgo Bioworks Holdings0.0228/02/2026
CABACabaletta Bio0.0228/02/2026
AURAAura Biosciences0.0228/02/2026
ACRSAclaris Therapeutics0.0228/02/2026
TRDAEntrada Therapeutics0.0228/02/2026
  1    2    3    4    5    6    7    8    9    10   11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.